Myung Gyu Kim

Myung Gyu Kim

orcid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2015 in Molecular Brain
Verified
Journal Article
Open access
PDF file
KCKang-Ho Choi
Kang-Ho Choi
MPMan-seok Park
Man-seok Park
HKHYUNG-SEOK KIM
HYUNG-SEOK KIM
KKKyung-Tae Kim
Kyung-Tae Kim
HKHyeon-Sik Kim
Hyeon-Sik Kim
KCKi-Hyun Cho
Ki-Hyun Cho
The antioxidant properties of alpha-lipoic acid (aLA) correlate with its ability to promote neuroproliferation. However, there have been no comprehensive studies examining the neurorestorative effects of aLA administration after the onset of ischemia. The middle cerebral artery (MCA) of adult rats was occluded for 2 hours and then reperfused. aLA (20 mg/kg) was administered in 71 animals (aLA group) through the left external jugular vein immediately after reperfusion. An equivalent volume of vehicle was administered to 71 animals (control group). Functional outcome, levels of endogenous neural precursors with neurogenesis, glial cell activation, and brain metabolism were evaluated. Immediate aLA administration after reperfusion resulted in significantly reduced mortality, infarct size, and neurological deficit score (NDS) in the test group compared to the control group. Long-term functional outcomes, measured by the rotarod test, were markedly improved by aLA treatment. There was a significant increase in the number of cells expressing nestin and GFAP in the boundary zone and infarct core regions after aLA treatment. Furthermore, significantly more BrdU/GFAP, BrdU/DCX, and BrdU/NeuN double-labeled cells were observed along the boundary zone of the aLA group on days 7, 14, and 28 days, respectively. And brain metabolism using 18F-FDG microPET imaging was markedly improved in aLA group. The effects of aLA was blocked by insulin receptor inhibitor, HNMPA (AM)3. These results indicate that immediate treatment with aLA after ischemic injury may have significant neurorestorative effects mediated at least partially via insulin receptor activation. Thus, aLA may be useful for the treatment of acute ischemic stroke.

1 January 2006 in Journal of Korean Medical Science
Verified
Journal Article
Open access
MSMin-Kyung Song
Min-Kyung Song
MKMyung Gyu Kim
Myung Gyu Kim
TKTae-Sun Kim
Tae-Sun Kim
SJSung-Pil Joo
Sung-Pil Joo
MPMan-Seok Park
Man-Seok Park
KCKi-Hyun Cho
Ki-Hyun Cho
We aimed to elucidate whether the eNOS T-786C mutant allele is implicated in subarachnoid hemorrhage (SAH) susceptibility or vasospasm after SAH, and whether the mutant allele is differentially expressed in those with small and large ruptured aneurysms in Korean population. 136 consecutive patients diagnosed with aneurismal SAH and 113 controls were recruited. Polymerase chain reaction and direct sequencing of both strands were performed to determine genotypes with respect to the eNOS T-786C mutation. No significant difference was found between cases and controls with respect to the distributions of the two eNOS T-786C single nucleotide polymorphism (SNP) genotypes. No significant differences in the distributions of the eNOS T-786C SNP genotypes were found with regard to the sizes of ruptured aneurysms or the occurrence of vasospasm after SAH. Multiple logistic regression analysis after controlling for age and sex showed the eNOS T-786C SNP T/C geno-type was independently associated with an unfavorable outcome (GOS grade 3-5) of SAH (Exp (beta)=4.27, 95% CI 1.131-16.108, p=0.032). In conclusion, the eNOS T-786C mutation was not found to be associated with either a susceptibility to SAH or vasospasm after SAH, or with aneurysm size in Korean population. The eNOS T-786C SNP T/C genotype could be used as a prognostic marker in individuals with SAH.

1 November 2010 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
MKMyung Gyu Kim
Myung Gyu Kim
OKOh-Young Kwon
Oh-Young Kwon
YCYong-Won Cho
Yong-Won Cho
YKYosik Kim
Yosik Kim
SKSung-Eun Kim
Sung-Eun Kim
ILIl Keun Lee
Il Keun Lee

1 November 2015 in Neuromuscular Disorders
Verified
Journal Article
Closed access
TNTai-Seung Nam
Tai-Seung Nam
WLWenting Li
Wenting Li
SHSuk-Hee Heo
Suk-Hee Heo
KLKyung-Hwa Lee
Kyung-Hwa Lee
ACAnna Cho
Anna Cho
SCSeok-Yong Choi
Seok-Yong Choi

16 November 2011 in European Neurology
Verified
Journal Article
Closed access
JKJoon-Tae Kim
Joon-Tae Kim
MPMan-seok Park
Man-seok Park
GYGeum-Jin Yoon
Geum-Jin Yoon
HJHyunjung Jung
Hyunjung Jung
KCKang-Ho Choi
Kang-Ho Choi
KCKi-Hyun Cho
Ki-Hyun Cho
Background: Mood disorder is a frequent complication of stroke. Comorbid depressive and anxiety disorders are very common, indicating that it is advisable to assess both disorders at the same time. The aim of the present study was to examine the prevalence of post-stroke depression (PSD) and poststroke anxiety (PSA) at baseline and to evaluate factors related to delayed PSD and PSA at 3 months after stroke onset. Methods: This was a prospectively registered and retrospectively analyzed study of patients with acute ischemic stroke between January 2009 and March 2010. Patients included in this study were interviewed in order to evaluate their Hospital Anxiety and Depression Scale (HADS) scores. In this study, each depression and anxiety score was dichotomized into ‘nondepressive and nonanxious’ (HADS-D and HADS-A ≤7) and ‘depressive and anxious’ (HADS-D and HADS-A >7). Multiple logistic regression analysis was used to evaluate the independent factors of depressive and anxious symptoms 3 months after stroke onset. Results: Of the 133 patients, 47.4% were ‘depressive’ and 56.4% were ‘anxious’ at baseline. The depressive and anxious groups had a significantly higher frequency of severe white matter hyperintensity (WMH) than the nondepressive and nonanxious groups (p < 0.05). The independent factors of PSD and PSA at 3 months were deep white matter hyperintensities (DWMH) and modified Rankin scale 0 to 1 at 3 months. Conclusion: In conclusions, the results of our study demonstrated that delayed depression and anxiety after ischemic stroke were related to the severity of DWMH and unfavorable outcomes at 3 months, regardless of anti-anxiety treatment. Our results suggested that WMH might be associated with pathomechanism of delayed depression and anxiety.

1 January 2012 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
SCSeong-Min Choi
Seong-Min Choi
BCBang-Hoon Cho
Bang-Hoon Cho
KCKang-Ho Choi
Kang-Ho Choi
TNTai-Seung Nam
Tai-Seung Nam
JKJoon-Tae Kim
Joon-Tae Kim
KCKi-Hyun Cho
Ki-Hyun Cho
Choi SM, et al. J Clin Neurol. 2012 Mar;8(1):79-82. http://dx.doi.org/10.3988/jcn.2012.8.1.79